All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)

Total Real Returns

ABT: Total Real Return Chart (Dividends Reinvested, Inflation Adjusted)

ABT real return snapshot: after CPI-U inflation, ABT returned โˆ’35.13% over the past year and โˆ’30.11% YTD, with dividends reinvested. Since Mar. 17, 1980, ABT is up +11,902.62% in real purchasing-power return, or +10.91%/yr, and is currently โˆ’42.61% below its real total-return high on Dec. 27, 2021.

Data ending Thu Jun. 11, 2026

Mon 1980-03-17๐Ÿ’ฌ to Thu 2026-06-11 YTD
Return
1 Year
Return
ABT
×
โˆ’30.11%
2026-06-11
โˆ’35.13%
2026-06-11
Abbott Laboratories NYSE Common Stock

Returns

Mon 1980-03-17๐Ÿ’ฌ to Thu 2026-06-11 Overall
Return
Exponential
Trendline
ABT
×
+11,902.62%
+10.91%/yr
+10.93%/yr
(R2=0.954)
Abbott Laboratories NYSE Common Stock

Growth of $10,000

Mon 1980-03-17๐Ÿ’ฌ to Thu 2026-06-11 Start
Value
End
Value
ABT
×
$10,000.00
1980-03-17
$1,200,262.14
2026-06-11
Abbott Laboratories NYSE Common Stock

Annual Returns

Year ABT
2026 (YTD) โˆ’30.11%
2025 +9.93%
2024 +1.88%
2023 โˆ’1.05%
2022 โˆ’25.50%
2021 +21.95%
2020 +26.32%
2019 +19.35%
2018 +26.65%
2017 +48.88%
2016 โˆ’14.10%
2015 +1.13%
2014 +19.18%
2013 +22.12%
2012 +18.25%
2011 +18.26%
2010 โˆ’9.62%
2009 +1.80%
2008 โˆ’2.57%
2007 +13.40%
2006 +23.75%
2005 โˆ’16.35%
2004 +14.09%
2003 +17.07%
2002 โˆ’28.43%
2001 +15.29%
2000 +31.39%
1999 โˆ’26.76%
1998 +49.46%
1997 +29.76%
1996 +20.56%
1995 +27.21%
1994 +10.03%
1993 โˆ’2.66%
1992 โˆ’12.63%
1991 +51.46%
1990 +27.44%
1989 +38.29%
1988 โˆ’2.11%
1987 +3.48%
1986 +34.58%
1985 +62.03%
1984 โˆ’8.76%
1983 +14.95%
1982 +38.22%
1981 โˆ’12.26%
1980 +45.70%

Drawdowns

Mon 1980-03-17๐Ÿ’ฌ to Thu 2026-06-11 Current
Drawdown
Worst
Drawdown
ABT
×
โˆ’42.61%
from 2021-12-27 peak
โˆ’46.87%
2026-05-11
from 2021-12-27 peak
Abbott Laboratories NYSE Common Stock

Rolling Returns

Period ending Thu 2026-06-11 1
Year
2
Years
3
Years
5
Years
10
Years
ABT
×
โˆ’35.13% โˆ’17.43%
โˆ’9.13%/yr
โˆ’15.05%
โˆ’5.29%/yr
โˆ’27.87%
โˆ’6.32%/yr
+101.82%
+7.27%/yr
Abbott Laboratories NYSE Common Stock